XTNT Xtant Medical Holdings Inc

Price (delayed)

$0.47

Market cap

$65.36M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.12

Enterprise value

$94.28M

Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal ...

Highlights
The revenue is up by 28% year-on-year and by 3% since the previous quarter
The company's gross profit rose by 23% YoY
XTNT's debt is up by 49% year-on-year but it is down by 2.2% since the previous quarter
Xtant Medical Holdings's quick ratio has decreased by 19% YoY but it has increased by 15% from the previous quarter
The equity has contracted by 16% YoY and by 6% from the previous quarter
Xtant Medical Holdings's gross margin has decreased by 4.4% from the previous quarter and by 4.3% YoY

Key stats

What are the main financial stats of XTNT
Market
Shares outstanding
139.07M
Market cap
$65.36M
Enterprise value
$94.28M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.52
Price to sales (P/S)
0.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.8
Earnings
Revenue
$117.27M
Gross profit
$68.22M
Operating income
-$12.07M
Net income
-$16.45M
EBIT
-$12.1M
EBITDA
-$7.88M
Free cash flow
-$15.63M
Per share
EPS
-$0.12
EPS diluted
-$0.12
Free cash flow per share
-$0.12
Book value per share
$0.31
Revenue per share
$0.88
TBVPS
$0.58
Balance sheet
Total assets
$93.84M
Total liabilities
$50.87M
Debt
$35.14M
Equity
$42.96M
Working capital
$38.54M
Liquidity
Debt to equity
0.82
Current ratio
2.35
Quick ratio
0.94
Net debt/EBITDA
-3.67
Margins
EBITDA margin
-6.7%
Gross margin
58.2%
Net margin
-14%
Operating margin
-10.3%
Efficiency
Return on assets
-17.2%
Return on equity
-36.3%
Return on invested capital
-15.6%
Return on capital employed
-18.5%
Return on sales
-10.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

XTNT stock price

How has the Xtant Medical Holdings stock price performed over time
Intraday
-0.02%
1 week
-1.88%
1 month
-7.83%
1 year
-52.51%
YTD
6.09%
QTD
0%

Financial performance

How have Xtant Medical Holdings's revenue and profit performed over time
Revenue
$117.27M
Gross profit
$68.22M
Operating income
-$12.07M
Net income
-$16.45M
Gross margin
58.2%
Net margin
-14%
The revenue is up by 28% year-on-year and by 3% since the previous quarter
The company's gross profit rose by 23% YoY
XTNT's operating income is down by 19% year-on-year but it is up by 14% since the previous quarter
Xtant Medical Holdings's operating margin has increased by 16% from the previous quarter and by 7% YoY

Growth

What is Xtant Medical Holdings's growth rate over time

Valuation

What is Xtant Medical Holdings stock price valuation
P/E
N/A
P/B
1.52
P/S
0.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.8
The company's EPS rose by 8% QoQ
XTNT's P/B is 46% below its 5-year quarterly average of 2.8 and 28% below its last 4 quarters average of 2.1
The equity has contracted by 16% YoY and by 6% from the previous quarter
The stock's price to sales (P/S) is 55% less than its 5-year quarterly average of 1.2 and 40% less than its last 4 quarters average of 0.9
The revenue is up by 28% year-on-year and by 3% since the previous quarter

Efficiency

How efficient is Xtant Medical Holdings business performance
Xtant Medical Holdings's ROIC has increased by 10% from the previous quarter
The company's return on sales rose by 10% QoQ
Xtant Medical Holdings's ROA has increased by 7% from the previous quarter
The ROE has grown by 2.2% from the previous quarter

Dividends

What is XTNT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for XTNT.

Financial health

How did Xtant Medical Holdings financials performed over time
The total assets is 84% more than the total liabilities
Xtant Medical Holdings's total liabilities has increased by 23% YoY but it has decreased by 4.3% from the previous quarter
Xtant Medical Holdings's quick ratio has decreased by 19% YoY but it has increased by 15% from the previous quarter
XTNT's debt is 18% smaller than its equity
The debt to equity has soared by 78% YoY and by 3.8% from the previous quarter
XTNT's debt is up by 49% year-on-year but it is down by 2.2% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.